Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2229642rdf:typepubmed:Citationlld:pubmed
pubmed-article:2229642lifeskim:mentionsumls-concept:C0022567lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0006772lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0040077lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0243126lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:2229642lifeskim:mentionsumls-concept:C0078437lld:lifeskim
pubmed-article:2229642pubmed:issue7lld:pubmed
pubmed-article:2229642pubmed:dateCreated1990-12-7lld:pubmed
pubmed-article:2229642pubmed:abstractTextAlthough calmodulin has been suggested as an important regulator of keratinocyte proliferation, its precise role remains unknown. We employed a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), to examine the role of calmodulin on keratinocyte proliferation. N-(6 aminohexyl-1-naphthalenesulfonamide (W-5), a chlorine-deficient analogue of W-7 with little anti-calmodulin activity, was used as the control. W-7 markedly inhibited thymidine incorporation of pig epidermis at concentrations close to its anti-calmodulin activity; W-5 had no effect on the thymidine incorporation. The inhibitory effect of W-7 was reversible; the removal of W-7 from the incubation medium resulted in the reinitiation of the thymidine incorporation, suggesting that W-7 is not a cytotoxic agent. These results are consistent with the view that calmodulin is an essential regulator of keratinocyte proliferation. The epidermal beta-adrenergic response, which is decreased in various hyperproliferative epidermal abnormalities, was increased in W-7-treated hypoproliferative epidermis. The epidermal SOD activity, which is also decreased in the hyperproliferative epidermis, however, was not affected by the W-7 treatment.lld:pubmed
pubmed-article:2229642pubmed:languageenglld:pubmed
pubmed-article:2229642pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:citationSubsetIMlld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2229642pubmed:statusMEDLINElld:pubmed
pubmed-article:2229642pubmed:monthJullld:pubmed
pubmed-article:2229642pubmed:issn0385-2407lld:pubmed
pubmed-article:2229642pubmed:authorpubmed-author:IizukaHHlld:pubmed
pubmed-article:2229642pubmed:authorpubmed-author:HashimotoYYlld:pubmed
pubmed-article:2229642pubmed:authorpubmed-author:MizumotoTTlld:pubmed
pubmed-article:2229642pubmed:authorpubmed-author:OhkumaNNlld:pubmed
pubmed-article:2229642pubmed:authorpubmed-author:HirokawaMMlld:pubmed
pubmed-article:2229642pubmed:issnTypePrintlld:pubmed
pubmed-article:2229642pubmed:volume17lld:pubmed
pubmed-article:2229642pubmed:ownerNLMlld:pubmed
pubmed-article:2229642pubmed:authorsCompleteYlld:pubmed
pubmed-article:2229642pubmed:pagination403-8lld:pubmed
pubmed-article:2229642pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:meshHeadingpubmed-meshheading:2229642-...lld:pubmed
pubmed-article:2229642pubmed:year1990lld:pubmed
pubmed-article:2229642pubmed:articleTitleReversible inhibition of keratinocyte thymidine incorporation by the calmodulin antagonist, W-7.lld:pubmed
pubmed-article:2229642pubmed:affiliationDepartment of Dermatology, Asahikawa Medical College, Japan.lld:pubmed
pubmed-article:2229642pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2229642pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed